Eversheds Dublin advises Endo Health on $1.7bn takeover of Paladin Labs
The Dublin office of Eversheds has advised on the takeover by Endo Health Solutions of Paladin Labs Europe for approximately $1.7bn (£1.1bn).
The acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target. An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction, and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
Partners Abigail St John Kennedy, Piaras Power and Darragh Blake and solicitors Darran Nangle and Niamh McMahon from the corporate banking team acted for Endo Health.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
Technology acquisitions round-up — Facebook acquires LiveRail; Apple acquires Beats Electronics; and more
In this briefing, Eversheds sets out a choice pick of mergers and acquisitions from 2014 so far.
In Carewatch Care Services v Focus Caring Service and Others, Mr Justice Henderson had to consider the enforceability of standard post-termination restrictions.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe